AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
CEFTRIAXONE MONOTHERAPY IN THE TREATMENT OF 376 EPISODES WITH LOW-RISK FEBRILE NEUTROPENIA
Authors: KARTHAUS M WOLF HH EGERER G KAMPFE D HOFFKNECHT M JURGENS H
Citation: M. Karthaus et al., CEFTRIAXONE MONOTHERAPY IN THE TREATMENT OF 376 EPISODES WITH LOW-RISK FEBRILE NEUTROPENIA, Annals of oncology, 9, 1998, pp. 678-678
CEFTRIAXONE IN THE TREATMENT OF SOLID TUMOR PATIENTS WITH FEBRILE NEUTROPENIA
Authors: KARTHAUS M WOLF HH EGERER G KAMPFE D SUEDHOFF T RITTER J JURGENS H
Citation: M. Karthaus et al., CEFTRIAXONE IN THE TREATMENT OF SOLID TUMOR PATIENTS WITH FEBRILE NEUTROPENIA, Onkologie, 21(3), 1998, pp. 212-216
PATIENT-CONTROLLED VERSUS STAFF-CONTROLLED ANALGESIA WITH PETHIDINE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: ZUCKER TP FLESCHE CW GERMING U SCHROTER S WILLERS R WOLF HH HEYLL A
Citation: Tp. Zucker et al., PATIENT-CONTROLLED VERSUS STAFF-CONTROLLED ANALGESIA WITH PETHIDINE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Pain, 75(2-3), 1998, pp. 305-312
PRECLINICAL EVALUATION OF PNU-151774E AS A NOVEL ANTICONVULSANT
Authors: FARIELLO RG MCARTHUR RA BONSIGNORI A CERVINI MA MAJ R MARRARI P PEVARELLO P WOLF HH WOODHEAD JW WHITE HS VARASI M SALVATI P POST C
Citation: Rg. Fariello et al., PRECLINICAL EVALUATION OF PNU-151774E AS A NOVEL ANTICONVULSANT, The Journal of pharmacology and experimental therapeutics, 285(2), 1998, pp. 397-403
FREE-RADICAL SCAVENGERS DIFFERENTIALLY MODULATE ANTI-IGE-INDUCED HISTAMINE-RELEASE FROM HUMAN SKIN MAST-CELLS
Authors: GIBBS BF WOLF HH GRABBE J
Citation: Bf. Gibbs et al., FREE-RADICAL SCAVENGERS DIFFERENTIALLY MODULATE ANTI-IGE-INDUCED HISTAMINE-RELEASE FROM HUMAN SKIN MAST-CELLS, Journal of investigative dermatology, 110(4), 1998, pp. 684-684
MONITORING OF MULTIPLE-MYELOMA PATIENTS BY SIMULTANEOUSLY MEASURING MARKER SUBSTANCES OF BONE-RESORPTION AND FORMATION
Authors: WITHOLD W ARNING M SCHWARZ M WOLF HH SCHNEIDER W
Citation: W. Withold et al., MONITORING OF MULTIPLE-MYELOMA PATIENTS BY SIMULTANEOUSLY MEASURING MARKER SUBSTANCES OF BONE-RESORPTION AND FORMATION, Clinica chimica acta, 269(1), 1998, pp. 21-30
CEFTRIAXONE MONOTHERAPY IN THE TREATMENT OF LOW-RISK FEBRILE NEUTROPENIA
Authors: KARTHAUS M WOLF HH KAMPFE D EGERER G RITTER J PETERS G SUDHOFF T FRANKE A HEIL G KULLMANN KH JURGENS H
Citation: M. Karthaus et al., CEFTRIAXONE MONOTHERAPY IN THE TREATMENT OF LOW-RISK FEBRILE NEUTROPENIA, Chemotherapy, 44(5), 1998, pp. 343-354
ONCE-DAILY ADMINISTRATION OF CEFTRIAXONE IN 420 PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND FEBRILE NEUTROPENIA
Authors: KARTHAUS M SUEDHOFF T WOLF HH EGERER G HEIL G RITTER J JURGENS H
Citation: M. Karthaus et al., ONCE-DAILY ADMINISTRATION OF CEFTRIAXONE IN 420 PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND FEBRILE NEUTROPENIA, British Journal of Haematology, 102(1), 1998, pp. 94-94
MANAGEMENT OF FEBRILE NEUTROPENIA IN 272 EPISODES IN SOLID TUMOR PATIENTS WITH ONCE-DAILY ADMINISTRATION OF CEFTRIAXONE
Authors: KARTHAUS M WOLF HH KAMPFE D RITTER J PETERS G JURGENS H
Citation: M. Karthaus et al., MANAGEMENT OF FEBRILE NEUTROPENIA IN 272 EPISODES IN SOLID TUMOR PATIENTS WITH ONCE-DAILY ADMINISTRATION OF CEFTRIAXONE, European journal of cancer, 33, 1997, pp. 234-234
TOPIRAMATE ENHANCES GABA-MEDIATED CHLORIDE FLUX AND GABA-EVOKED CHLORIDE CURRENTS IN MURINE BRAIN NEURONS AND INCREASES SEIZURE THRESHOLD
Authors: WHITE HS BROWN SD WOODHEAD JH SKEEN GA WOLF HH
Citation: Hs. White et al., TOPIRAMATE ENHANCES GABA-MEDIATED CHLORIDE FLUX AND GABA-EVOKED CHLORIDE CURRENTS IN MURINE BRAIN NEURONS AND INCREASES SEIZURE THRESHOLD, Epilepsy research, 28(3), 1997, pp. 167-179
AWD-140-190 - A NEW ANTICONVULSANT WITH A VERY GOOD MARGIN OF SAFETY
Authors: ROSTOCK A TOBER C RUNDFELDT C BARTSCH R UNVERFERTH K ENGEL J WOLF HH WHITE HS
Citation: A. Rostock et al., AWD-140-190 - A NEW ANTICONVULSANT WITH A VERY GOOD MARGIN OF SAFETY, Epilepsy research, 28(1), 1997, pp. 17-28
PRECLINICAL CHARACTERIZATION OF MDL-27,192 AS A POTENTIAL BROAD-SPECTRUM ANTICONVULSANT AGENT WITH NEUROPROTECTIVE PROPERTIES
Authors: KEHNE JH KANE JM CHANEY SF HURST G MCCLOSKEY TC PETTY MA SENYAH Y WOLF HH ZOBRIST R WHITE HS
Citation: Jh. Kehne et al., PRECLINICAL CHARACTERIZATION OF MDL-27,192 AS A POTENTIAL BROAD-SPECTRUM ANTICONVULSANT AGENT WITH NEUROPROTECTIVE PROPERTIES, Epilepsy research, 27(1), 1997, pp. 41-54
BONE-MARROW TRANSPLANTATION - PERSPECTIVE S AS A COMMON TASK IN EUROPE
Authors: WOLF HH
Citation: Hh. Wolf, BONE-MARROW TRANSPLANTATION - PERSPECTIVE S AS A COMMON TASK IN EUROPE, Die medizinische Welt, 48(1), 1997, pp. 28-32
CHARACTERIZATION OF THE ANTICONVULSANT PROPERTIES OF GANAXOLONE (CCD 1042, PHA-HYDROXY-3-BETA-METHYL-5-ALPHA-PREGNAN-20-ONE), A SELECTIVE, HIGH-AFFINITY, STEROID MODULATOR OF THE GAMMA-AMINOBUTYRIC ACID(A) RECEPTOR
Authors: CARTER RB WOOD PL WIELAND S HAWKINSON JE BELELLI D LAMBERT JJ WHITE HS WOLF HH MIRSADEGHI S TAHIR SH BOLGER MB LAN NC GEE KW
Citation: Rb. Carter et al., CHARACTERIZATION OF THE ANTICONVULSANT PROPERTIES OF GANAXOLONE (CCD 1042, PHA-HYDROXY-3-BETA-METHYL-5-ALPHA-PREGNAN-20-ONE), A SELECTIVE, HIGH-AFFINITY, STEROID MODULATOR OF THE GAMMA-AMINOBUTYRIC ACID(A) RECEPTOR, The Journal of pharmacology and experimental therapeutics, 280(3), 1997, pp. 1284-1295
AROYL(AMINOACYL)PYRROLES, A NEW CLASS OF ANTICONVULSANT AGENTS
Authors: CARSON JR CARMOSIN RJ PITIS PM VAUGHT JL ALMOND HR STABLES JP WOLF HH SWINYARD EA WHITE HS
Citation: Jr. Carson et al., AROYL(AMINOACYL)PYRROLES, A NEW CLASS OF ANTICONVULSANT AGENTS, Journal of medicinal chemistry, 40(11), 1997, pp. 1578-1584
SWINYARD,EWART,A. - (1909-1997)
Authors: WOLF HH
Citation: Hh. Wolf, SWINYARD,EWART,A. - (1909-1997), Epilepsia, 38(12), 1997, pp. 1366-1366
RELATIONSHIP BETWEEN BONE METABOLISM AND PLASMA CYTOKINE LEVELS IN PATIENTS AT RISK OF POSTTRANSPLANTATION BONE-DISEASE AFTER BONE-MARROW TRANSPLANTATION
Authors: WITHOLD W WOLF HH KOLLBACH S HEYLL A SCHNEIDER W REINAUER H
Citation: W. Withold et al., RELATIONSHIP BETWEEN BONE METABOLISM AND PLASMA CYTOKINE LEVELS IN PATIENTS AT RISK OF POSTTRANSPLANTATION BONE-DISEASE AFTER BONE-MARROW TRANSPLANTATION, European journal of clinical chemistry and clinical biochemistry, 34(4), 1996, pp. 295-299
MONITORING OF BONE METABOLISM AFTER BONE-MARROW TRANSPLANTATION BY MEASURING 2 DIFFERENT MARKERS OF BONE TURNOVER
Authors: WITHOLD W WOLF HH KOLLBACH S HEYLL A SCHNEIDER W REINAUER H
Citation: W. Withold et al., MONITORING OF BONE METABOLISM AFTER BONE-MARROW TRANSPLANTATION BY MEASURING 2 DIFFERENT MARKERS OF BONE TURNOVER, European journal of clinical chemistry and clinical biochemistry, 34(3), 1996, pp. 193-197
D-23129 - A NEW ANTICONVULSANT WITH A BROAD-SPECTRUM ACTIVITY IN ANIMAL-MODELS OF EPILEPTIC SEIZURES
Authors: ROSTOCK A TOBER C RUNDFELDT C BARTSCH R ENGEL J POLYMEROPOULOS EE KUTSCHER B LOSCHER W HONACK D WHITE HS WOLF HH
Citation: A. Rostock et al., D-23129 - A NEW ANTICONVULSANT WITH A BROAD-SPECTRUM ACTIVITY IN ANIMAL-MODELS OF EPILEPTIC SEIZURES, Epilepsy research, 23(3), 1996, pp. 211-223
QUALITATIVE ASSESSMENT OF MIXED CHIMERISM AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH REGARD TO LEUKEMIC RELAPSE
Authors: KOGLER G HERNANDEZ A HEYLL A WOLF HH WERNET P
Citation: G. Kogler et al., QUALITATIVE ASSESSMENT OF MIXED CHIMERISM AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH REGARD TO LEUKEMIC RELAPSE, Cancer detection and prevention, 20(6), 1996, pp. 601-609
MONITORING OF THERAPEUTIC OUTCOME IN PATIENTS WITH MULTIPLE-MYELOMA BY SIMULTANEOUSLY MEASURING 3 DIFFERENT BIOCHEMICAL MARKERS OF BONE METABOLISM
Authors: WITHOLD W ARNING M SCHWARZ M WOLF HH SCHNEIDER W REINAUER H
Citation: W. Withold et al., MONITORING OF THERAPEUTIC OUTCOME IN PATIENTS WITH MULTIPLE-MYELOMA BY SIMULTANEOUSLY MEASURING 3 DIFFERENT BIOCHEMICAL MARKERS OF BONE METABOLISM, Clinical chemistry, 42(6), 1996, pp. 722-722
PATIENT-CONTROLLED ANALGESIA REDUCES PETHIDINE REQUIREMENT AND IMPROVES PAIN RELIEF AFTER ALLOGENIC BONE-MARROW TRANSPLANTATION
Authors: ZUCKER TP FLESCHE CW GERMING U SCHROTER S WOLF HH HEYLL A
Citation: Tp. Zucker et al., PATIENT-CONTROLLED ANALGESIA REDUCES PETHIDINE REQUIREMENT AND IMPROVES PAIN RELIEF AFTER ALLOGENIC BONE-MARROW TRANSPLANTATION, British Journal of Anaesthesia, 76, 1996, pp. 409-409
A NEW PROTOCOL (BMMP) FOR THE TREATMENT OF REFRACTORY OR RELAPSED HIGH-GRADE NON-HODGKINS-LYMPHOMAS (NHL) OF ADVANCED-STAGE - A PHASE-I STUDY
Authors: KAHL C HEROLD M JENTSCHULLRICH K WOLF HH HOFFKES HG FRANKE A
Citation: C. Kahl et al., A NEW PROTOCOL (BMMP) FOR THE TREATMENT OF REFRACTORY OR RELAPSED HIGH-GRADE NON-HODGKINS-LYMPHOMAS (NHL) OF ADVANCED-STAGE - A PHASE-I STUDY, Blood, 88(10), 1996, pp. 3495-3495
MAINTAINING OUR COMMITMENT TO CHANGE
Authors: WOLF HH HEPLER CD KNAPP DA KODAKIMBLE MA MILLER KW NAHATA MC RUTLEDGE CO SMITH WE VANDEL JH YANCHICK VA
Citation: Hh. Wolf et al., MAINTAINING OUR COMMITMENT TO CHANGE, American journal of pharmaceutical education, 60(4), 1996, pp. 378-384
GRADUATE-EDUCATION - PROGRESS, PROBLEMS AND PROMISE
Authors: WOLF HH
Citation: Hh. Wolf, GRADUATE-EDUCATION - PROGRESS, PROBLEMS AND PROMISE, American journal of pharmaceutical education, 60(4), 1996, pp. 384-386
Risultati: 1-25 | 26-42